Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00473-2/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz-_dti1v009bsYEbDpAR7HSMk7kcu-h0Kd5IXTxdEEcHsUknIRcvdTlvIzqB5nJdzbz3bPW-JKm7w0ZH3vmlmH0G882Wrg&_hsmi=301365788&utm_content=301365788&utm_source=hs_email